241 related articles for article (PubMed ID: 32366847)
1. Genomic landscape of platinum resistant and sensitive testicular cancers.
Loveday C; Litchfield K; Proszek PZ; Cornish AJ; Santo F; Levy M; Macintyre G; Holryod A; Broderick P; Dudakia D; Benton B; Bakir MA; Hiley C; Grist E; Swanton C; Huddart R; Powles T; Chowdhury S; Shipley J; O'Connor S; Brenton JD; Reid A; de Castro DG; Houlston RS; Turnbull C
Nat Commun; 2020 May; 11(1):2189. PubMed ID: 32366847
[TBL] [Abstract][Full Text] [Related]
2. Genomic evolution and chemoresistance in germ-cell tumours.
Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
[TBL] [Abstract][Full Text] [Related]
3. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
4. Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Shen H; Shih J; Hollern DP; Wang L; Bowlby R; Tickoo SK; Thorsson V; Mungall AJ; Newton Y; Hegde AM; Armenia J; Sánchez-Vega F; Pluta J; Pyle LC; Mehra R; Reuter VE; Godoy G; Jones J; Shelley CS; Feldman DR; Vidal DO; Lessel D; Kulis T; Cárcano FM; Leraas KM; Lichtenberg TM; Brooks D; Cherniack AD; Cho J; Heiman DI; Kasaian K; Liu M; Noble MS; Xi L; Zhang H; Zhou W; ZenKlusen JC; Hutter CM; Felau I; Zhang J; Schultz N; Getz G; Meyerson M; Stuart JM; ; Akbani R; Wheeler DA; Laird PW; Nathanson KL; Cortessis VK; Hoadley KA
Cell Rep; 2018 Jun; 23(11):3392-3406. PubMed ID: 29898407
[TBL] [Abstract][Full Text] [Related]
5. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.
Litchfield K; Summersgill B; Yost S; Sultana R; Labreche K; Dudakia D; Renwick A; Seal S; Al-Saadi R; Broderick P; Turner NC; Houlston RS; Huddart R; Shipley J; Turnbull C
Nat Commun; 2015 Jan; 6():5973. PubMed ID: 25609015
[TBL] [Abstract][Full Text] [Related]
7. K-RAS and N-RAS mutations in testicular germ cell tumors.
Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
[TBL] [Abstract][Full Text] [Related]
8. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.
Goddard NC; McIntyre A; Summersgill B; Gilbert D; Kitazawa S; Shipley J
Int J Androl; 2007 Aug; 30(4):337-48; discussion 349. PubMed ID: 17573850
[TBL] [Abstract][Full Text] [Related]
9. Testicular germ cell tumor: a comprehensive review.
Batool A; Karimi N; Wu XN; Chen SR; Liu YX
Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
[TBL] [Abstract][Full Text] [Related]
10. Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan.
Sakuma Y; Matsukuma S; Yoshihara M; Sakurai S; Nishii M; Kishida T; Kubota Y; Nagashima Y; Inayama Y; Sasaki T; Nakamura Y; Miura T; Kameda Y; Tsuchiya E; Miyagi Y
Cancer Lett; 2008 Jan; 259(1):119-26. PubMed ID: 18006222
[TBL] [Abstract][Full Text] [Related]
11. Clonal analyses of refractory testicular germ cell tumors.
Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of KIT in familial testicular germ cell tumours.
Rapley EA; Hockley S; Warren W; Johnson L; Huddart R; Crockford G; Forman D; Leahy MG; Oliver DT; Tucker K; Friedlander M; Phillips KA; Hogg D; Jewett MA; Lohynska R; Daugaard G; Richard S; Heidenreich A; Geczi L; Bodrogi I; Olah E; Ormiston WJ; Daly PA; Looijenga LH; Guilford P; Aass N; Fosså SD; Heimdal K; Tjulandin SA; Liubchenko L; Stoll H; Weber W; Einhorn L; Weber BL; McMaster M; Greene MH; Bishop DT; Easton D; Stratton MR
Br J Cancer; 2004 Jun; 90(12):2397-401. PubMed ID: 15150569
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Brabrand S; Johannessen B; Axcrona U; Kraggerud SM; Berg KG; Bakken AC; Bruun J; Fosså SD; Lothe RA; Lehne G; Skotheim RI
Neoplasia; 2015 Feb; 17(2):167-74. PubMed ID: 25748235
[TBL] [Abstract][Full Text] [Related]
14. Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
[TBL] [Abstract][Full Text] [Related]
15. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
16. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
[TBL] [Abstract][Full Text] [Related]
17. The genetic landscape of 87 ovarian germ cell tumors.
Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
[TBL] [Abstract][Full Text] [Related]
18. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.
Romano FJ; Rossetti S; Conteduca V; Schepisi G; Cavaliere C; Di Franco R; La Mantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Quagliariello V; Piscitelli R; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; De Giorgi U; Facchini G
Oncotarget; 2016 Dec; 7(51):85641-85649. PubMed ID: 27821802
[TBL] [Abstract][Full Text] [Related]
20. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
